Novartis Ag NVS
NYSE NVS
$151.25 -4.01 (-2.58%)
At close: Nov 19, 2026 · 4:00 PM EST

Novartis Ag (NVS) Change in Receivables (2024 - 2025)

Updated

Novartis Ag (NVS) recorded Change in Receivables of -$1.04 billion in Q1 2025, compared with -$920 million a year earlier.

Analysis

Novartis Ag (NVS) Change in Receivables (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 85,477.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -188.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -312.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -52.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Pfizer 156.44 Bn 103.79 Bn 12.56 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -1.04 Bn
Mar 31, 2024 -920.00 Mn
API Access

Novartis Ag Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=NVS&period=max&api_key=YOUR_API_KEY